The Current Ratio as of December 2025 (TTM) for BioInvent International AB (publ) (BOVNF) is 7.40

According to BioInvent International AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 7.40. This represents a change of -16.17% compared to the average of 8.83 of the last 4 quarters.

BioInvent International AB (publ) (BOVNF) Historical Current Ratio (quarterly & annually)

How has BOVNF Current Ratio performed in the past?

The mean historical Current Ratio of BioInvent International AB (publ) over the last ten years is 8.97. The current 7.40 Current Ratio has changed 8.15% with respect to the historical average. Over the past ten years (40 quarters), BOVNF's Current Ratio was at its highest in in the June 2021 quarter at 27.99. The Current Ratio was at its lowest in in the March 2016 quarter at 1.97.

BioInvent International AB (publ) (BOVNF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioInvent International AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioInvent International AB (publ) (BOVNF) Average Current Ratio

How has BOVNF Current Ratio performed in the past?

The current Current Ratio of BioInvent International AB (publ) (BOVNF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioInvent International AB (publ) (BOVNF) Current Ratio vs. Peers

How is BOVNF’s Current Ratio compared to its peers?

BioInvent International AB (publ)’s Current Ratio is greater than Avacta Group Plc (1.08), greater than MedinCell S.A. (2.70), greater than Healios K.K. (1.06), less than Race Oncology Limited (10.29), less than PureTech Health plc (8.49), greater than Northwest Biotherapeutics, Inc. (0.08), greater than CytoDyn Inc. (0.19), less than Immutep Limited (11.69), greater than GenSight Biologics S.A. (0.24), less than Clinuvel Pharmaceuticals Limited (9.66),

Build a custom stock screener for BioInvent International AB (publ) (BOVNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioInvent International AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioInvent International AB (publ) (BOVNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioInvent International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.